Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Minerva Neurosciences Inc (NASDAQ:NERV)

14.19
Delayed Data
As of Sep 28
 +0.17 / +1.21%
Today’s Change
3.45
Today|||52-Week Range
15.84
+133.77%
Year-to-Date

Today’s Trading

Previous close14.02
Today’s open14.07
Day’s range13.82 - 14.22
Volume139,754
Average volume (3 months)1,045,518
Market cap$488.0M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+74.05%
Earnings growth (this year)+30.17%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.27

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp0.000.00%
RVNCRevance Therapeutics...+0.12+0.71%
CYNACynapsus Therapeutic...+0.07+0.17%
ENTAEnanta Pharmaceutica...+0.02+0.08%
Data as of 3:59pm ET, 09/28/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$27.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rémy Luthringer
Chief Operating Officer &
Senior Vice President
Joseph Reilly
Corporate headquarters
Waltham, Massachusetts

Forecasts

Search for Jobs